ClinicalTrials.Veeva

Menu

Functional Magnetic Resonance Imaging in Patients With Obstructive Sleep Apnea Syndrome (IRM SAOS)

C

CHU de Reims

Status

Enrolling

Conditions

Obstructive Sleep Apnea Syndrome

Treatments

Diagnostic Test: functional magnetic resonance imaging

Study type

Interventional

Funder types

Other

Identifiers

NCT05147649
PA21141*

Details and patient eligibility

About

The obstructive sleep apnea syndrome (OSAS) involves recurrent sleep-related upper airways (UA) collapse. UA mechanical properties and neural control are altered, imposing a mechanical load on inspiration. UA collapse does not occur during wakefulness, hence arousal-dependent compensation. Experimental inspiratory loading in normal subjects elicits respiratory-related cortical activity during wakefulness. The objective of this study is to test whether awake OSAS patients would exhibit a similar cortical activity. Whether or not such cortical compensatory mechanisms have cognitive consequences would be also analyze.

Enrollment

70 estimated patients

Sex

All

Ages

18 to 75 years old

Volunteers

Accepts Healthy Volunteers

Inclusion and exclusion criteria

Inclusion criteria :

  1. OSAS patients

    • severe OSAS with an Apnea-Hypopnea Index (AHI) > 30/h
    • without CPAP treatment
  2. Non-OSAS patients

    • absence of OSAS (AHI < 15/h and absence of excessive daytime sleepiness with Epworth score <11)

Non-inclusion criteria :

  • < 18 years old
  • >75 years old
  • left-handed
  • BMI> 40 kg/m²
  • another sleep disorder
  • central component of sleep apnea syndrome (central apnea index> 5 / h)
  • current or past neurological pathology
  • respiratory pathology (obstructive ventilatory disorder, restrictive ventilatory disorder, hypercapnia)
  • MRI contraindication (metallic foreign body, claustrophobia, pregnant woman, etc.)
  • taking drugs that can modify the BOLD signal on MRI (psychotropic drugs, vasodilators, vasoconstrictors, etc.),
  • uncorrected sensory impairment (vision or hearing)
  • protected by law.

Exclusion criteria :

  • pregnant woman according to the positive beta-hCG test result

  • left-handed following the laterality questionnaire

  • MINI results showing:

    • a current mood episode
    • a current disorder of the use of psychoactive substances or in the last 6 months (excluding tobacco)
    • an eating disorder
    • a diagnosis of bipolar disorder, current or past schizophrenia

Trial design

Primary purpose

Other

Allocation

Non-Randomized

Interventional model

Single Group Assignment

Masking

None (Open label)

70 participants in 2 patient groups

non-OSAS patients
Active Comparator group
Description:
Patients without OSAS (Apnea-Hypopnea Index (AHI) \< 15/h and absence of excessive daytime sleepiness with Epworth score \<11)
Treatment:
Diagnostic Test: functional magnetic resonance imaging
OSAS patients
Experimental group
Description:
Patients with severe OSAS with an Apnea-Hypopnea Index (AHI) \> 30/h
Treatment:
Diagnostic Test: functional magnetic resonance imaging

Trial contacts and locations

1

Loading...

Central trial contact

Claire Launois

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems